Open AccessAnticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
Author(s) -
Alan S. Go,
Elaine M. Hylek,
Yuchiao Chang,
Kathleen A. Phillips,
Lori Henault,
Angela M. Capra,
Nancy G. Jensvold,
Joe V. Selby,
Daniel E. Singer
Publication year - 2003
Publication title -
jama
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.290.20.2685
Subject(s) - medicine , warfarin , atrial fibrillation , stroke (engine) , odds ratio , hazard ratio , antithrombotic , aspirin , randomized controlled trial , embolism , cardiology , confidence interval , mechanical engineering , engineering
Warfarin has been shown to be highly efficacious for preventing thromboembolism in atrial fibrillation in randomized trials, but its effectiveness and safety in clinical practice is less clear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom